Aprea Therapeutics, Inc. SEC filings APRE
Aprea Therapeutics, Inc. has 446 filings in SEC EDGAR's recent list, going back to Jul 12, 2019. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Other events
|
Aug 28, 2026 | Aug 28, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2026 | — |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Listing notice
|
Jul 23, 2026 | Jul 23, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 16, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2026 | Jun 16, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 424B7 | Filing | May 15, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Other events
|
May 13, 2026 | May 13, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 16, 2026 |
| EFFECT | Filing | Apr 29, 2026 | — |
| 424B3 | Prospectus | Apr 29, 2026 | — |
| CORRESP | Letter to the SEC | Apr 27, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 27, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 27, 2026 | — |
| S-3 | Shelf registration | Apr 22, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Jun 16, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 7, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 1, 2026 | — |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 1, 2026 | Apr 1, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Mar 30, 2026 | Mar 30, 2026 |
| EFFECT | Filing | Mar 19, 2026 | — |
| 424B3 | Prospectus | Mar 19, 2026 | — |
| CORRESP | Letter to the SEC | Mar 17, 2026 | — |
| S-3/A | Filing | Mar 17, 2026 | — |
| 4 | Insider transaction | Mar 16, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Mar 16, 2026 | Mar 12, 2026 |
| S-8 | Employee stock plan registration | Mar 16, 2026 | — |
| CORRESP | Letter to the SEC | Mar 16, 2026 | — |
| 10-K | Annual report | Mar 16, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 16, 2026 | Mar 16, 2026 |
| UPLOAD | Letter from the SEC | Feb 24, 2026 | — |
| S-3 | Shelf registration | Feb 20, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 18, 2026 | Feb 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Feb 2, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jan 29, 2026 | Jan 28, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 28, 2026 | — |
| 8-K |
Current report
Listing notice
|
Jan 23, 2026 | Jan 23, 2026 |
| 8-K |
Current report
Other events
|
Jan 9, 2026 | Jan 9, 2026 |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| EFFECT | Filing | Dec 29, 2025 | — |
| D | Filing | Dec 29, 2025 | — |
| CORRESP | Letter to the SEC | Dec 23, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 23, 2025 | — |
| S-3 | Shelf registration | Dec 19, 2025 | — |
| 4 | Insider transaction | Dec 11, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 10, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 10, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 9, 2025 | Dec 8, 2025 |
| S-8 | Employee stock plan registration | Dec 8, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 17, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 12, 2025 | Nov 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 12, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 24, 2025 | Oct 24, 2025 |
| 8-K |
Current report
Other events
|
Oct 15, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Other events
|
Sep 8, 2025 | Sep 8, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 9, 2025 | Jun 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 14, 2025 | May 14, 2025 |
| ARS | Annual report to shareholders | Apr 22, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 22, 2025 | — |
| DEF 14A | Proxy statement | Apr 22, 2025 | Jun 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 8, 2025 | — |
| 4 | Insider transaction | Apr 4, 2025 | Apr 3, 2025 |
| 4 | Insider transaction | Mar 31, 2025 | Mar 27, 2025 |
| 4 | Insider transaction | Mar 31, 2025 | Mar 27, 2025 |
| 10-K | Annual report | Mar 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change, Other events
|
Mar 25, 2025 | Mar 25, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 10, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 10, 2025 | — |
| 8-K |
Current report
Other events
|
Feb 5, 2025 | Feb 5, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 13, 2025 | Jan 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| 8-K |
Current report
Material agreement
|
Nov 8, 2024 | Nov 8, 2024 |
| 424B5 | Prospectus supplement | Nov 8, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Nov 7, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 25, 2024 | Oct 18, 2024 |
| 4 | Insider transaction | Oct 24, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 23, 2024 | Oct 23, 2024 |
| 4 | Insider transaction | Oct 17, 2024 | Oct 16, 2024 |
| 4 | Insider transaction | Oct 16, 2024 | Oct 15, 2024 |
| 4 | Insider transaction | Oct 16, 2024 | Oct 14, 2024 |
| 4 | Insider transaction | Oct 16, 2024 | Oct 11, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Oct 11, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Oct 10, 2024 |
| 4 | Insider transaction | Oct 15, 2024 | Oct 10, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 10, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Oct 9, 2024 | Oct 9, 2024 |
| S-8 | Employee stock plan registration | Aug 21, 2024 | — |
| 8-K |
Current report
Results of operations, Other events
|
Aug 12, 2024 | Aug 12, 2024 |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Other events
|
Jun 17, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
May 14, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 4 | Insider transaction | May 2, 2024 | May 1, 2024 |
| 3 | Initial insider ownership | May 2, 2024 | May 1, 2024 |
| 424B3 | Prospectus | Apr 30, 2024 | — |
| EFFECT | Filing | Apr 29, 2024 | — |
| CORRESP | Letter to the SEC | Apr 25, 2024 | — |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Other events
|
Apr 10, 2024 | Apr 10, 2024 |
| UPLOAD | Letter from the SEC | Apr 8, 2024 | — |
| S-3 | Shelf registration | Apr 3, 2024 | — |
| 4 | Insider transaction | Mar 28, 2024 | Mar 28, 2024 |
| 4 | Insider transaction | Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 26, 2024 | Mar 26, 2024 |
| 10-K | Annual report | Mar 26, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Mar 14, 2024 | Mar 13, 2024 |
| 4 | Insider transaction | Mar 14, 2024 | Mar 13, 2024 |
| 4 | Insider transaction | Mar 14, 2024 | Mar 13, 2024 |
| 4 | Insider transaction | Mar 14, 2024 | Mar 13, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure, Other events
|
Mar 12, 2024 | Mar 11, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 14, 2024 | — |
| 424B3 | Prospectus | Feb 9, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 7, 2024 | — |
| 8-K |
Current report
Other events
|
Feb 6, 2024 | Feb 6, 2024 |
| 424B3 | Prospectus | Feb 5, 2024 | — |
| EFFECT | Filing | Feb 2, 2024 | — |
| 8-K |
Current report
Results of operations
|
Feb 2, 2024 | Feb 2, 2024 |
| CORRESP | Letter to the SEC | Jan 31, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2024 | — |
| 8-K |
Current report
Material agreement
|
Jan 26, 2024 | Jan 26, 2024 |
| S-3 | Shelf registration | Jan 26, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 4, 2024 | Jan 4, 2024 |
| S-8 | Employee stock plan registration | Nov 9, 2023 | — |
| 8-K |
Current report
Results of operations, Other events
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Other events
|
Oct 16, 2023 | Oct 16, 2023 |
| 8-K |
Current report
Other events
|
Oct 13, 2023 | Oct 13, 2023 |
| 8-K |
Current report
Other events
|
Sep 11, 2023 | Sep 11, 2023 |
| 4 | Insider transaction | Aug 24, 2023 | Aug 23, 2022 |
| 4 | Insider transaction | Aug 24, 2023 | Aug 23, 2023 |
| 4 | Insider transaction | Aug 24, 2023 | Aug 23, 2023 |
| 4 | Insider transaction | Aug 24, 2023 | Aug 23, 2023 |
| 4 | Insider transaction | Aug 24, 2023 | Aug 23, 2023 |
| 4 | Insider transaction | Aug 24, 2023 | Aug 23, 2023 |
| 4 | Insider transaction | Aug 24, 2023 | Aug 23, 2023 |
| 3 | Initial insider ownership | Aug 24, 2023 | Aug 23, 2023 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 24, 2023 | Aug 23, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Aug 10, 2023 | Aug 10, 2023 |
| ARS | Annual report to shareholders | Jul 11, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Jul 11, 2023 | Aug 23, 2023 |
| 8-K |
Current report
Listing notice
|
Jul 5, 2023 | Jul 3, 2023 |
| 4 | Insider transaction | Jun 8, 2023 | Jun 6, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
May 15, 2023 | May 15, 2023 |
| 4 | Insider transaction | May 8, 2023 | May 5, 2023 |
| 3 | Initial insider ownership | May 8, 2023 | May 5, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
May 8, 2023 | May 5, 2023 |
| 10-K/A | Amended annual report | Apr 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Auditor change
|
Apr 18, 2023 | Apr 17, 2023 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Mar 30, 2023 | Mar 30, 2023 |
| 4 | Insider transaction | Mar 13, 2023 | Aug 23, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 13, 2023 |
| SC 13G | Ownership over 5% (passive) | Mar 3, 2023 | — |
| 8-K |
Current report
Other events
|
Mar 1, 2023 | Mar 1, 2023 |
| 4 | Insider transaction | Feb 27, 2023 | Feb 27, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- APRE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Doylestown, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1781983
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.